Company profile: Congenica
1.1 - Company Overview
Company description
- Provider of a clinical genomic diagnostic decision support platform. Sapientia integrates human DNA sequences with deep clinical phenotyping to enable actionable interpretation. Offerings include automated analysis for inherited diseases, somatic oncology, rare disease diagnosis, pathogen surveillance and pharma insights, upcoming pharmacogenomics, plus professional services for implementation.
Products and services
- Congenica Rare Disease: Clinical-grade software that rapidly analyzes and interprets next-generation sequencing data to diagnose rare diseases, delivering actionable genetic interpretation for clinicians
- Automated Analysis and Diagnostic Platform: Enterprise-scale system that integrates human DNA sequences with deep clinical phenotyping to analyze inherited diseases, somatic cancer, pharma insights, and pathogen surveillance with actionable interpretation
- Somatic Oncology: End-to-end system for routine oncology clinical practice, supporting patient care with automated analysis focused on somatic cancer
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Congenica
MIDI
HQ: United States
Website
- Description: Provider of chemical analysis and microbial identification solutions for agriculture and environmental microbiology laboratories.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full MIDI company profile →
Nightstar Therapeutics
HQ: United Kingdom
Website
- Description: Provider of biopharmaceutical gene therapy research and development focused on retinal dystrophies, aiming to enable treatments for rare conditions caused by single-gene mutations; U.K. startup.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Nightstar Therapeutics company profile →
Seek Labs
HQ: United States
Website
- Description: Provider of CRISPR-based technology targeting cellular replication to eliminate a cell or pathogen’s ability to replicate, CRISPR-based pharmaceuticals, point-of-care molecular diagnostic tools, laboratory-quality molecular diagnostic testing at the point of care, genetic material purification, and a secure digital platform to communicate easy-to-understand diagnostic results and track health trends.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Seek Labs company profile →
Pierian
HQ: United States
Website
- Description: Provider of genomic SaaS solutions, a CAP and CLIA accredited laboratory, and a shared knowledgebase to enable physicians in the laboratory and clinic to diagnose and treat cancer and other complex diseases. Offerings include the Clinical Genomics Workspace, a knowledgebase with over 350,000 inferencing rules, professional services, IVD partnerships, EMR/LIS/EDW integration, and wet lab workflow guidance.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Pierian company profile →
Raptor Pharma
HQ: United States
Website
- Description: Provider of biopharmaceutical therapeutics, engaging in discovery, research and preclinical development of drug candidates and drug-targeting platforms for brain and neurodegenerative diseases, genetic disorders and cancer, and commercializing TEPEZZA for Thyroid Eye Disease and UPLIZNA for neuromyelitis optica spectrum disorder in AQP4 antibody-positive adults.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Raptor Pharma company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Congenica
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Congenica
2.2 - Growth funds investing in similar companies to Congenica
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Congenica
4.2 - Public trading comparable groups for Congenica
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →